This is the standing evidence sheet for Arvinas (ARVN): the yardsticks BullScope computes from official SEC filings and market prices. It refreshes whenever a new edition of our research is published, and it is impersonal by design, every reader sees the same page. Nothing here is investment advice; it is the evidence, organized.
The price tag: what buyers pay per dollar of profit
Arvinas is priced at 1.7× its annual sales (typical for this company over its past decade: 20.5×).
The tape: what the stock itself has done
- Last price: $6.87 (end-of-day market data as of the edition date · methodology) · 50% below its 52-week high
- Past 6 months: -27.1% · past 12 months: -38.7%
- Day-to-day temperament: jumpy (annualized volatility 56%)
The filed record: straight from the annual reports
| Fiscal year | Revenue | Growth | Operating margin | EPS |
|---|---|---|---|---|
| FY2021 | $0.0B | +114.2% | -418.2% | $-3.82 |
| FY2022 | $0.1B | +181.4% | -200.3% | $-5.31 |
| FY2023 | $0.1B | -40.3% | -511.5% | $-6.62 |
| FY2024 | $0.3B | +235.5% | -95.0% | $-2.77 |
| FY2025 | $0.3B | -0.3% | -45.1% | $-1.14 |
The road ahead: filed results vs published expectations
| FY2023A | FY2024A | FY2025A | FY2026E | FY2027E | |
|---|---|---|---|---|---|
| Net sales ($B) | 0.10 | 0.30 | 0.30 | 0.28 to 0.38 | 0.22 to 0.46 |
| Net sales growth (%) | – | ~+200 | – | 7 | 0 |
| Operating margin (%) | -400 | -100 | -45 | -55 to -35 | -65 to -25 |
| Diluted EPS ($) | -6.62 | -2.77 | -1.14 | -2.80 to -1.20 | -3.50 to -0.80 |
Columns marked A are actual filed results; E columns are the published consensus ranges the current price is being weighed against.
The four gauges: from the latest edition
BullScope coverage of Arvinas
Read the full report on Arvinas in the BullScope Terminal → It opens with this company loaded.
Edition date: 2026-11-13. This page updates when a new edition is published. Sources: SEC EDGAR filings, Nasdaq prices; computed by BullScope’s published methodology.









